Cierra N. Sharp

Cierra N. Sharp

Aug 15, 2016

Group 6 Copy 1
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How does hemlock tree decline impact bird bioindicators and ecosystem condition?

    An invasive insect, the Hemlock Woolly Adelgid (HWA), is causing Eastern Hemlock tree decline in the Appalachian...

    Do turtles have enough variation in adaptive genes to keep pace with climate change?

    Climate change is expected to have impacts on biodiversity worldwide. Many species will be faced with a choice...

    Backer Badge Funded